Overview

Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This study aimed to verify the survival benefit of TS-1 plus CDDP combination chemotherapy compared with the monotherapy by TS-1 alone.
Phase:
Phase 3
Details
Lead Sponsor:
Taiho Pharmaceutical Co., Ltd.
Treatments:
Cisplatin